218 related articles for article (PubMed ID: 33483129)
1. Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group.
Berthelsen DB; Woodworth TG; Goel N; Ioannidis JPA; Tugwell P; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Leong AL; Conaghan PG; Boers M; Shea BJ; Brooks PM; Simon LS; Furst DE; Christensen R;
Semin Arthritis Rheum; 2021 Jun; 51(3):607-617. PubMed ID: 33483129
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Detecting Algorithmic Errors and Patient Harms for AI-Enabled Medical Devices in Randomized Controlled Trials: Protocol for a Systematic Review.
Kale AU; Hogg HDJ; Pearson R; Glocker B; Golder S; Coombe A; Waring J; Liu X; Moore DJ; Denniston AK
JMIR Res Protoc; 2024 Jun; 13():e51614. PubMed ID: 38941147
[TBL] [Abstract][Full Text] [Related]
4. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review.
Mohiuddin MM; Mizubuti G; Haroutounian S; Smith S; Campbell F; Park R; Gilron I
JMIR Res Protoc; 2019 Jan; 8(1):e11637. PubMed ID: 30688655
[TBL] [Abstract][Full Text] [Related]
5. Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World Use.
Stach CM; Sloan VS; Woodworth TG; Kilgallen B; Furst DE
Drug Saf; 2019 Dec; 42(12):1499-1506. PubMed ID: 31696432
[TBL] [Abstract][Full Text] [Related]
6. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
Morillon MB; Nørup A; Singh JA; Dalbeth N; Taylor WJ; Kennedy MA; Pedersen BM; Grainger R; Tugwell P; Perez-Ruiz F; Diaz-Torne C; Edwards NL; Shea B; Ellingsen TJ; Christensen R; Stamp LK;
Semin Arthritis Rheum; 2023 Jun; 60():152191. PubMed ID: 36963128
[TBL] [Abstract][Full Text] [Related]
7. Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review.
Moskowitz A; Andersen LW; Holmberg MJ; Grossestreuer AV; Berg KM; Granfeldt A
Crit Care; 2020 Jul; 24(1):398. PubMed ID: 32641148
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and harms of pharmacological interventions for the treatment of delirium in adults in intensive care units after cardiac surgery: a systematic review.
Leigh V; Stern C; Elliott R; Tufanaru C
JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2020-2074. PubMed ID: 31449136
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.
Mayo-Wilson E; Fusco N; Hong H; Li T; Canner JK; Dickersin K
Trials; 2019 Sep; 20(1):553. PubMed ID: 31488200
[TBL] [Abstract][Full Text] [Related]
10. What do we really know about the safety of tai chi?: A systematic review of adverse event reports in randomized trials.
Wayne PM; Berkowitz DL; Litrownik DE; Buring JE; Yeh GY
Arch Phys Med Rehabil; 2014 Dec; 95(12):2470-83. PubMed ID: 24878398
[TBL] [Abstract][Full Text] [Related]
11. Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited.
Tedesco D; Farid-Kapadia M; Offringa M; Bhutta ZA; Maldonado Y; Ioannidis JPA; Contopoulos-Ioannidis DG
J Clin Epidemiol; 2018 Mar; 95():63-72. PubMed ID: 29191447
[TBL] [Abstract][Full Text] [Related]
12. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Colchicine for acute gout.
van Echteld I; Wechalekar MD; Schlesinger N; Buchbinder R; Aletaha D
Cochrane Database Syst Rev; 2014 Aug; (8):CD006190. PubMed ID: 25123076
[TBL] [Abstract][Full Text] [Related]
15. Second-generation antidepressants for preventing seasonal affective disorder in adults.
Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
[TBL] [Abstract][Full Text] [Related]
16. Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
Holch P; Henry AM; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Albutt A; Velikova G
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):495-510. PubMed ID: 28126299
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
